000			01498 a2200433 4500
005			20250516075444.0
264		0	_c20120223
008			201202s 0 0 rus d
022			_a0040-3660
040			_aNLM _beng _cNLM
100	1		_aNovikov, P I
245	0	0	_a[Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment]. _h[electronic resource]
260			_bTerapevticheskii arkhiv _c2011
300			_a70-6 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntibodies, Monoclonal, Murine-Derived _xadverse effects
650	0	4	_aAntigens, CD20 _ximmunology
650	0	4	_aB-Lymphocytes _ximmunology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aGlucocorticoids _xadministration & dosage
650	0	4	_aGranulomatosis with Polyangiitis _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunologic Factors _xadverse effects
650	0	4	_aKidney Diseases _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrednisolone _xadministration & dosage
650	0	4	_aRecurrence
650	0	4	_aRemission Induction _xmethods
650	0	4	_aRituximab
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aKrivosheev, O G
700	1		_aSemenkova, E N
773	0		_tTerapevticheskii arkhiv _gvol. 83 _gno. 11 _gp. 70-6
999			_c21525094 _d21525094